Search results
Available fetal therapies, including medical management for arrhythmias or heart failure and closed or open intervention for diseases affecting the cardiovascular system such as twin–twin transfusion syndrome, lung masses, and vascular tumors, are highlighted.
- View Full Text
The diagnosis of cardiac disease in the fetus is mostly made...
- View Full Text
24 kwi 2014 · The diagnosis of cardiac disease in the fetus is mostly made with ultrasound; however, new technologies, including 3- and 4-dimensional echocardiography, magnetic resonance imaging, and fetal electrocardiography and magnetocardiography, are available.
Indications for performance of fetal echocardiography (Table 1), the gold standard test to diagnose congenital heart disease (CHD) in the fetus, have evolved over the years. The discussion in this section hinges on the quality and sensitivity of prenatal ultrasound screening for cardiac abnormalities, the basic or detailed obstetric anatomic ul-
18 lut 2023 · Diagnosis of FHF is based on various fetal echocardiographic findings, depending on the severity of cardiac dysfunction, including cardiomegaly, poor contractility, low cardiac output, venous congestion, effusions, and typical findings of specific cardiac anomalies.
Working Groups: Thrombosis, Grown-up Congenital Heart Disease, Hypertension and the Heart, Pulmonary Circulation and Right Ventricular Function, Valvular Heart Disease, Cardiovascular Pharmacology and Drug Therapy, Acute Cardiac Care, Cardiovascular Surgery.
27 maj 2014 · Available fetal therapies, including medical management for arrhythmias or heart failure and closed or open intervention for diseases affecting the cardiovascular system such as twin-twin transfusion syndrome, lung masses, and vascular tumors, are highlighted.
Abstract. Fetal echocardiography has progressed to be able to diagnose many forms of congenital heart disease and to assess the prognosis of cardiac lesions based on their anatomy and presentation in utero. However, the presence of signs of fetal heart failure, such as hydrops or valvular regurgitation, makes the assessment of prognosis difficult.
